Sun Pharma Acquires Organon in $11.75 Billion Deal – India’s Biggest Overseas Pharma Buy
Sun Pharma will buy Organon for $11.75B, boosting global reach, women’s health, and specialty drugs, and creating a $12.4B annual revenue pharma giant.
/ 4 items
#OGN↓
Indian Pharma Giant Sun Pharma Launches $13 Billion Takeover Bid for Organon
Sun Pharma offers $13B to buy Organon, aiming to expand globally in branded drugs, competing with EQT and Grünenthal.
Sun Pharma Makes Massive $12 Billion Binding Offer for US Firm Organon
Sun Pharma fell 4% after a $12B bid for Organon, raising debt worries despite strong cash and ongoing deal talks.
Organon CEO Steps Down After Sales Practice Investigation
Organon's (OGN) CEO Kevin Ali resigns following internal probe into Nexplanon birth-control implant sales practices. Company appoints interim chief and implements corrective measures.